Cell and Gene at AbbeyCell and Gene at the Abbey

Production, Scale-up and Global Harmonisation

Conference Agenda

DAY 01: 10TH NOVEMBER 2021
08.30 Aoife Duffy / Brian Harrison HiTech Health Introduction.
09.00 Benjamin Gysi Takeda Pharmaceutical Update on Takeda´s Cell Therapy Strategy Development.
09.45 Mandana Haack-Sørensen Rigshospitalet Automation of cell therapy manufacturing: Lessons learned on compliance, product quality and production consistency
10.30 COFFEE
11.00 Scott Olson University of Texas Developing Potency Measures of MSC and MSC-like Products.
11.45 Prof. Francesco Curcio University of Udine Clinical use of MSCs: the experience at the University of Udine Medical Centre.
12.30 LUNCH
14.00 Shirley O'Dea Avectas Solupore Non-viral Cell Engineering Platform.
14.45 Nisha Durand Mayo Clinic Insights into the Operations of a small cGMP Cell Therapy Manufacturing Facility in an Academic Setting.
15.30 COFFEE
16.00 Qasim Rafiq University College London Automated Process Development and Manufacturing Strategies for ATMPs.
16.45 Steve Charlebois MedInstitute Ancillary materials for CGT manufacturing: considerations for validation, optimization, and automation.
18.00 Drinks Reception
19.30 Dinner @ Glenlo
DAY 02: 11TH NOVEMBER 2021
09.00 Bruce Levine UPenn Development, Regulatory Approval, and Improvements in Engineered T Cell Therapies.
09.45 Máire Quigley CRISPR Therapeutics Allogeneic CAR-T Cell Therapy.
10.30 COFFEE
11.00 Massimo Dominici University Hospital of Modena and Reggio Emilia Modena, Italy Scaling up anti-cancer gene therapies: challenges and opportunities.
11.45 Roisin O'Cearbhaill Memorial Sloane Kettering Overcoming challenges of cellular therapies in solid tumours.
12.30 LUNCH
13.45 Knut Niss MustangBio From MSCs to CARTs: How Manufacturing of ATMPs changed over the Last Decade.
14.30 Mark Lowdell University College London What are the appropriate release criteria and analytical tools for ATMPs.
15.15 Niamh Curran HPRA - Health Products Regulatory Authority ATMPs - A regulatory update and lessons learned so far.
16.00 COFFEE
16.30 Workshop
18.30 Dinner in Galway City
DAY 03: 12TH NOVEMBER 2021
09.00 TBC TBC Facilitating complex relationships with multiple contract manufacturers to deliver cell and gene therapies.
09.45 Bernd Kullman Sigilon Therapeutics ATMP Manufacturing, Release, and Distribution: establishing a supply network and reducing risk for a time and temperature sensitive product.
10.30 COFFEE
11.00 Patrick Hanley Children's National Hospital, The George Washington University Overcoming Challenges in the Cellular Therapy Laboratory.
11.45 Jason Jones OriBiotech Challenging the Paradigms of CGT Manufacturing Technology.
12.30 Jim Faulkner / Michael O’Dwyer Venture Partner / ONK Therapeutics Investing in cell/gene therapies.
13.15 LUNCH

Fee & Cancellation Policy

Rate includes 2.5 days conference attendance with workshop on Day 2, coffees, lunches, a drinks reception and 2 dinners. 


Early Bird Registration, before April 30th, 2021

€1,250 per attendee 

2 or more from one company €1,000 per attendee 


General Registration, after May 01st, 2021

€1,500 per attendee 

2 or more from one company €1,250 per attendee 


Academic rate available upon request.

Cancellation possible until September 30th subject to a €100.00 cancellation fee.



Accommodation is available at the Glenlo Abbey Hotel, and can be booked directly via the hotel or via e-mail at reservation@glenloabbey.ie using promo-codeHiTechHealth’. Special rate of 160 B&B single or 170 for Twin or Double.

In addition, rooms are also available at the Harbour Hotel (www.harbour.ie located in Galway City. Bookings can be made directly via the hotel or via e-mail at reservations@harbour.ie using promo-code ‘HiTechHealth. Special rate of €129 B&B single or €139 for Twin or Double. Transfer will be organised for attendees staying in this hotel to the venue each morning of the meeting.

HiTech-Health awarded with government funding

HiTech Health awarded with €7m government funding for 'disruptive' project   HiTech Health and our partners, Relevium Medical and Professor Garry Duffy’s Laboratory at NUI Galway are honoured to receive €7 million from the Disruptive Technologies Innovation Fund...

Stay Up To Date

Connect with us to receive the latest HiTech Health and industry updates.